Covered recipient · General Payments record
ROLAND R MORE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2020–2024
$2,133.19
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $635.30 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $187.21 | 10 |
| EISAI INC. | $177.77 | 3 |
| Lundbeck LLC | $49.07 | 2 |
| PFIZER INC. | $44.43 | 2 |
| Amneal Pharmaceuticals LLC | $42.08 | 2 |
| Neurocrine BioSciences, Inc. | $41.88 | 2 |
| Genentech USA, Inc. | $37.73 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.91 | 1 |
| Lilly USA, LLC | $16.07 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $7.93 | 01/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064266 | CMS |
| ABBVIE INC. | $23.84 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064268 | CMS |
| ABBVIE INC. | $28.75 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064270 | CMS |
| ABBVIE INC. | $13.10 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064272 | CMS |
| ABBVIE INC. | $23.83 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064274 | CMS |
| ABBVIE INC. | $22.47 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064276 | CMS |
| ABBVIE INC. | $25.52 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064278 | CMS |
| ABBVIE INC. | $7.85 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064280 | CMS |
| ABBVIE INC. | $15.67 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064282 | CMS |
| ABBVIE INC. | $18.25 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105064284 | CMS |
| Amneal Pharmaceuticals LLC | $18.33 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139195732 | CMS |
| Amneal Pharmaceuticals LLC | $23.75 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139195734 | CMS |
| Eisai Inc. | $24.10 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110777747 | CMS |
| Eisai Inc. | $124.25 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110777743 | CMS |
| Eisai Inc. | $29.42 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110777745 | CMS |
| Genentech USA, Inc. | $14.77 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133101188 | CMS |
| Genentech USA, Inc. | $22.96 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133101192 | CMS |
| Lilly USA, LLC | $16.07 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135374010 | CMS |
| Lundbeck LLC | $29.58 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145948114 | CMS |
| Lundbeck LLC | $19.49 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145948116 | CMS |
| Neurocrine Biosciences, Inc. | $16.81 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150869608 | CMS |
| Neurocrine Biosciences, Inc. | $25.07 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150839642 | CMS |
| Novartis Pharmaceuticals Corporation | $25.91 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087126972 | CMS |
| PFIZER INC. | $23.72 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131271461 | CMS |
| PFIZER INC. | $20.71 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131068903 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.15 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151698154 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.